News & Events
-
May 28, 2013
Qualitative Development and Cognitive Evaluation of the Symptoms of Major Depressive Disorder (S-MDD), A Consortium-Developed Patient Reported Outcome Measure
McCarrier K, Abraham L, Blum S, Bush E, Bushnell D, Carpenter L, Coons S, Houle C, Martin M, Mathews M, Trivedi M, Thase M, on behalf of the PRO Consortium Depression Working Group. Qualitative Development and Cognitive Evaluation of the Symptoms of Major Depressive Disorder (S-MDD), A Consortium-Developed Patient Reported Outcome Measure. 53rd New Clinical Drug Evaluation Unit (NCDEU): An Annual Meeting Sponsored by the American Society of Clinical Psychopharmacology (ASCP); 2013 May 28; Hollywood, FL, USA.
-
May 23, 2013
Leading US and European Medical Public-Private Partnerships Announce Agreement
The Predictive Safety Testing Consortium (PSTC) led by the Critical Path Institute (C-Path) and the Safer and Faster Evidence-based Translation (SAFE-T) consortium sponsored by the Innovative Medicines Initiative (IMI), announced today the signature of an agreement to work together in their efforts to improve drug safety. - May 22, 2013
- May 20, 2013
- May 18, 2013
